title: Hepatic protection by perioperative metabolic support?
abstract: OBJECTIVE
  We report the case of a 63-y-old woman undergoing left hepatectomy for hilar cholangiocarcinoma who was at high risk of postoperative liver failure due to an atrophic right liver lobe. She participated in a randomized clinical trial investigating the effect of perioperative glucose infusion on hepatic function after major liver resection.
  
  
  METHODS
  Intravenous glucose was initiated the night before the operation at 2 mg x kg(-1) x min(-1). During and after the operation, glucose was administered with a continuous insulin infusion until the first postoperative day. Postoperative liver function was assessed by the score proposed by Schindl, evaluating total serum bilirubin and plasma lactate concentrations, prothrombin time, and the grade of encephalopathy.
  
  
  RESULTS
  The patient's liver dysfunction was classified as "mild" on postoperative day 1 and as "none" on postoperative day 2. Postoperative liver function scores were better than those observed in a control group of patients who underwent hepatic resection of similar magnitude without glucose/insulin therapy.
  
  
  CONCLUSIONS
  Perioperative glucose/insulin administration was associated with a surprisingly small deterioration of liver function after left lobe liver resection in the presence of an atrophic right lobe. A randomized clinical trial will have to determine whether glucose/insulin therapy can improve hepatic function after major liver resections.
authors.affiliation: Department of Surgery, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada.
authors.forename: Mazen
authors.initials: M
authors.lastname: Hassanain
authors.forename: Thomas
authors.initials: T
authors.lastname: Schricker
authors.forename: Peter
authors.initials: P
authors.lastname: Metrakos
authors.forename: George
authors.initials: G
authors.lastname: Carvalho
authors.forename: Dionisios
authors.initials: D
authors.lastname: Vrochides
authors.forename: Ralph
authors.initials: R
authors.lastname: Lattermann
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D005260:Female; D005947:Glucose / Q000008:administration & dosage* / Q000494:pharmacology; D006498:Hepatectomy; D006801:Humans; D007263:Infusions, Parenteral / Q000379:methods; D007328:Insulin / Q000008:administration & dosage* / Q000494:pharmacology; D017093:Liver Failure / Q000517:prevention & control*; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000601:surgery*; D008875:Middle Aged; D019990:Perioperative Care / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D007328:Insulin; D005947:Glucose